One way leads to a future in which AI-driven breakthroughs remain the exclusive domain of pharmaceutical giants with billion-dollar budgets. The other, to a landscape where breakthroughs regularly ...

The raise comes less than two months after Ricursive was launched by former Google LLC researchers Anna Goldie and Azalia ...

The ability to experience a common reality is being systematically dismantled The post Trump Is the Greatest Hypnotist of Our Time first appeared on The Walrus.

Many in the AI community believe that the next major revolution will be the era of self-improving AI where AI can improve ...

Sundance: Telling three parallel stories at various points in time, Stanton's film spans 47,000 years in search of a single believable moment.

DeFi has evolved from 2020’s yield chaos into real financial infrastructure. Here’s how stablecoins, RWAs, and institutions ...

The evidence shows that, under controlled conditions, LLM judges can align closely with clinician judgments on concrete, ...

Explore Dogecoin price prediction 2026 & XRP current price action shape the market while ZKP emerges as the next crypto to ...

Nvidia is turning its AI firepower toward the hardest problems in medicine, striking multibillion-dollar alliances with pharmaceutical and biotech heavyweights to rewire how drugs are discovered and ...

ChatGPT’s newest model has been caught leaning on Grokipedia, an AI-written encyclopedia created by Elon Musk’s xAI, to ...

While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.